Our pipeline is focused on unlocking the potential of advanced cellular therapies through allogeneic cells, by exploring investigational approaches for clinical areas with limited therapeutic options. We focus on the use of mesenchymal stem cells for regenerative tissue in dermatology. In addition, we are involved in external programs focused on inmune restoration using allogeneic cells, offering a scalable manufacturing infraestructure compliant with current European regulatory standards.
Dermatology
AGA
Mesenchymal stem cells
Allogenic
WO/2025/133317
Immunology
Heart Transplant Children
Thymic cells
Autologous
WO/2019/16665
EP3759215
The first pre-clinical research program exploring an allogeneic therapy with mesenchymal stem cells for androgenetic alopecia
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique identifiers on this site. Not consenting or withdrawing consent may negatively affect certain features and functions.